USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 6, 2022 (est) | Jun 30, 2022 | - | - | $-0.11 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 6, 2022 (est) | Jun 30, 2022 | - | $0.00 | $0.00 |
Aslan Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $-0.20 | $-0.20 | $-0.20 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $-0.56 | $-0.79 | $-0.42 |
| Dec 2023 | 2 | $-0.95 | $-1.41 | $-0.50 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 1 | $-0.17 | $-0.17 | $-0.17 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 1 | $-0.53 | $-0.53 | $-0.53 |
| Dec 2023 | 0 / 0 | $-0.50 | $-0.50 | $-0.50 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $0.00 | $0.00 | $0.00 |
| Dec 2023 | 2 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Apr 28, 2022 | Mar 2022 | $-0.18 | - | - |
| Mar 25, 2022 | Dec 2021 | $-0.14 | $-0.16 | -14.29% |
| Oct 26, 2021 | Sep 2021 | $-0.12 | $-0.12 | - |
| Aug 6, 2021 | Jun 2021 | $-0.08 | $-0.11 | -39.00% |
| Apr 22, 2021 | Mar 2021 | $-0.05 | $-0.15 | -200.00% |
| Dec 31, 2020 | Dec 2020 | $-0.10 | $-0.15 | -50.00% |
| Nov 9, 2020 | Sep 2020 | $-0.05 | $-0.10 | -114.13% |
| Jul 13, 2020 | Jun 2020 | $-0.10 | $-0.10 | - |
| May 11, 2020 | Mar 2020 | $-0.12 | $-0.10 | 16.67% |
| Mar 18, 2020 | Dec 2019 | $-0.16 | $-0.90 | -462.50% |
| Oct 31, 2019 | Sep 2019 | $-0.23 | $-0.15 | 34.78% |
| Aug 13, 2019 | Jun 2019 | $-0.20 | $-0.25 | -25.00% |
| Apr 29, 2019 | Mar 2019 | $-0.18 | $-0.15 | 16.67% |
| Mar 22, 2019 | Dec 2018 | $-0.38 | $-0.35 | 6.67% |
| Nov 7, 2018 | Sep 2018 | $-0.34 | $-0.35 | -2.94% |
| Aug 3, 2018 | Jun 2018 | $-0.31 | $-0.35 | -11.71% |
| May 8, 2018 | Mar 2018 | - | $-0.33 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 25, 2022 | Dec 2021 | $-0.48 | $-0.54 | - |
| Dec 31, 2020 | Dec 2020 | $0.00 | $-0.45 | - |
| Mar 18, 2020 | Dec 2019 | $-0.70 | $-1.45 | - |
| Mar 22, 2019 | Dec 2018 | $-1.40 | $-1.38 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Apr 28, 2022 | Mar 2022 | $0.00 | $0.00 | - |
| Mar 25, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Oct 26, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 6, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| Apr 22, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Dec 31, 2020 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 9, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Jul 13, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 11, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 18, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Oct 31, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 13, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| Apr 29, 2019 | Mar 2019 | $3.00M | $3.00M | 1.00% |
| Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 7, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 3, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 8, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 25, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Dec 31, 2020 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 18, 2020 | Dec 2019 | $3.00M | $3.00M | 0.00% |
| Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
ASLN's next estimated earnings date (based on same quarter last year's report date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.
Aslan Pharmaceuticals's previous earnings date was Apr 28, 2022 for its fiscal quarter ended Mar 31, 2022.
Revenues were $0.00.
The company reported a net income of $-12.94M.Aslan Pharmaceuticals's previous annual earnings date was Mar 25, 2022 for its fiscal year ended Dec 31, 2021.
ASLN's earnings per share (EPS) was $-0.54, missing the consensus analysts forecast of $-0.48 by 12.75% , and lower than the previous year's EPS (Dec 2020) by 20.27%.
Revenues were $0.00.
The company reported a net income of $-31.32M.
Aslan Pharmaceuticals reported a free cash flow of $-34.04M for its fiscal year, compared to $-15.06M a year ago.
The company ended the fiscal year with $31.06M in total debt, an increase of 63.68% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
